VISFO
Knowledge base
Clinical landscape snapshot
Get a full-picture view of the clinical reality in any indication, combining epidemiology, disease burden, and unmet need into one streamlined starting point.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Criteria 2
Criteria 3
Criteria 4
Criteria 5
Criteria 6
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
- Your addressable population by country, region, or demographic
- Health system strain through hospitalisation, resource use, and cost metrics
- Key points of clinical failure, misdiagnosis, or patient drop-off
- Gaps in the current treatment paradigm and quality-of-life indicators
Analyze
- Quantify unmet need across geographies and patient subgroups
- Prioritise high-burden segments for R&D, trials, or early access
- Benchmark disease understanding across regulators and HTAs
- Build a robust case for indication selection or expansion
Stay ahead with a clinical snapshot that’s continuously refreshed, easy to interrogate, and designed to de-risk decision-making across early development and launch
Use cases
How can this help your team...
Medical Affairs
Understand the real-world impact of disease across populations
Tailor scientific narratives to reflect lived clinical burden
Support external engagement with credible, up-to-date data
Market Access
Strengthen value stories with hard epidemiological and burden data
Align access strategies with high-need geographies and populations
Identify payer-relevant evidence gaps early in the development cycle
Clinical Development
Focus trial design on high-prevalence regions and subgroups
Justify indication selection with robust burden-of-disease evidence
Inform recruitment strategies with real-world patient distribution insights
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
